4
Changes in Ownership
Cue Biopharma, Inc. Filed Acc 0000899243-21-006358
Options or other derivatives
- CEO acquired 85,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| PASSERI DANIEL R CEO | 2021-02-10 | Grant or award · Stock Option (right to buy) | +85,000 | 85,000 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…